Aggrenox (Boehringer Ingelheim Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the Aggrenox drug offered from Boehringer Ingelheim Pharmaceuticals, Inc.. This Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE],Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Boehringer Ingelheim Pharmaceuticals, Inc. |
| NON-PROPRIETARY NAME: | aspirin and dipyridamole |
| SUBSTANCE NAME: | ASPIRIN; DIPYRIDAMOLE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE],Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE, EXTENDED RELEASE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1999-12-19 |
| END MARKETING DATE: | 0000-00-00 |
Aggrenox HUMAN PRESCRIPTION DRUG Details:
| Item Description | Aggrenox from Boehringer Ingelheim Pharmaceuticals, Inc. |
| LABELER NAME: | Boehringer Ingelheim Pharmaceuticals, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 25; 200(mg/1; mg/1) |
| START MARKETING DATE: | 1999-12-19 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0597-0001_f0a7d9c9-c119-aae0-ae19-4e96ffadff01 |
| PRODUCT NDC: | 0597-0001 |
| APPLICATION NUMBER: | NDA020884 |
Other ASPIRIN; DIPYRIDAMOLE Pharmaceutical Manufacturers / Labelers:
